Cargando…

Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

PURPOSE: To report the outcomes of half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). METHODS: A chart review of patients with chronic CSC who had received half-dose verteporfin PDT (3 mg/m(2)) was performed. The main outcome measures were resolutio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naseripour, Masood, Falavarjani, Khalil Ghasemi, Sedaghat, Ahad, Moghaddam, Arezoo Karimi, Nasserisina, Sadaf, Alemzadeh, Sayyed Amirpooya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860990/ https://www.ncbi.nlm.nih.gov/pubmed/27195088 http://dx.doi.org/10.4103/2008-322X.180706

Ejemplares similares

Differentiating a pachychoroid and healthy choroid using an unsupervised machine learning approach
por: Mirshahi, Reza, et al.
Publicado: (2022)

Optical coherence tomography angiography (OCTA) applications in ocular oncology
por: Naseripour, Masood, et al.
Publicado: (2020)

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
por: Ratanasukon, Mansing, et al.
Publicado: (2013)

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
por: Servillo, Andrea, et al.
Publicado: (2023)

Retinotomy and Retinectomy in the Management of Rhegmatogenous Retinal Detachment Associated with Advanced Proliferative Vitreoretinopathy
por: Zand, Amin, et al.
Publicado: (2022)

Photodynamic Therapy and Central Serous Chorioretinopathy
por: Siaudvytyte, Lina, et al.
Publicado: (2012)

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
por: Fujita, Kyoko, et al.
Publicado: (2012)

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak, Thuss, et al.
Publicado: (2015)

Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
por: Alovisi, Camilla, et al.
Publicado: (2020)

Segmentation Error Correction of the Optical Coherence Tomography Angiography Images in Peer-Reviewed Studies
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2022)

Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2017)

Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
por: Al-Hinai, Ahmed S., et al.
Publicado: (2011)

Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy
por: Ma, Dae Joong, et al.
Publicado: (2018)

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
por: Atik, Alp, et al.
Publicado: (2017)

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
por: Horiguchi, Etsuyo, et al.
Publicado: (2022)

Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
por: Ng, Winnie WK, et al.
Publicado: (2011)

Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
por: Kinoshita, Takamasa, et al.
Publicado: (2016)

Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
por: Nassisi, Marco, et al.
Publicado: (2017)

Long-Term Effect of Half-Fluence Photodynamic Therapy on Fundus Autofluorescence in Acute Central Serous Chorioretinopathy
por: Stattin, Martin, et al.
Publicado: (2020)

Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
por: Zeng, Miao, et al.
Publicado: (2022)

Half-fluence Photodynamic Therapy for Central Serous Chorioretinopathy in a Patient Receiving Corticosteroids for Behçet’s Uveitis
por: Özdemir, Hüseyin Baran, et al.
Publicado: (2022)

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Feenstra, Helena M. A., et al.
Publicado: (2023)

Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate
por: Naseripour, Masood, et al.
Publicado: (2016)

Ocular safety of intravitreal ethylene diamine tetra acetic acid (EDTA): An experimental feasibility study
por: Zand, Amin, et al.
Publicado: (2023)

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2014)

Long-Term Effects of Half-Time Photodynamic Therapy on Retinal Sensitivity in Eyes with Chronic Central Serous Chorioretinopathy
por: Iwase, Takehito, et al.
Publicado: (2020)

Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report
por: Zhang, Zhengwei, et al.
Publicado: (2021)

Two-year outcome of half-time photodynamic therapy for chronic central serous chorioretinopathy with and without choroidal neovascularization
por: Kamimura, Aya, et al.
Publicado: (2023)

New Hope for Retinoblastoma Patients
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2010)

Isolates and Antibiotic Resistance of Culture-Proven Endophthalmitis Cases Presented to a Referral Center in Tehran
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2012)

Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy
por: Khandhadia, Samir, et al.
Publicado: (2022)

Foveal Avascular Zone and Vessel Density in Healthy Subjects: An Optical Coherence Tomography Angiography Study
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2018)

One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
por: Pichai, Jirarattanasopa, et al.
Publicado: (2021)

Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
por: Fujita, Kyoko, et al.
Publicado: (2020)

Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Kumashiro, Shun, et al.
Publicado: (2021)

Retinocytoma associated with bilateral retinoblastoma
por: Naseripour, Masood, et al.
Publicado: (2010)

Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy
por: Tsakonas, George D, et al.
Publicado: (2012)

Structural and Functional Outcomes in Chronic Central Serous Chorioretinopathy Treated with Photodynamic Therapy
por: Cidad, Pino, et al.
Publicado: (2015)

Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
por: Ruiz-del-Tiempo, María Pilar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_egam53lvjr49afinonqp1r7q68